Google, COVID-19 test provider partner to create biothreat-detection system: 3 things to know

Google and Cue Health, Google’s COVID-19 test provider, are planning to create an advanced respiratory biothreat-detection system, according to a Sept. 24 CNBC report.

Advertisement

Three things to know:

  1. Google Cloud and Cue Health have partnered to develop real-time variant tracking and sequencing of COVID-19, according to the report. 
  2. The duo aims to create a respiratory biothreat-detection system that spans from at-home diagnostic tests to real-time viral sequencing, as well as analytical and predictive capabilities with Google Cloud, according to CNBC.
  3. Google started using Cue Health’s COVID-19 tests for its employees after discovering Cue Health was a client of Google Cloud. Cue Health’s tests do not require a lab for processing, and patients are able to get their results from a nasal swab on a phone app within 20 minutes.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Digital Health

Advertisement

Comments are closed.